会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • HYDROGEL COMPOSITE DEPOT FORMULATION
    • 水凝胶复合料制剂
    • WO2017068245A1
    • 2017-04-27
    • PCT/FI2016/050745
    • 2016-10-21
    • DELSITECH OY
    • LEINO, LasseJALONEN, HarryFORSBACK, Ari-PekkaJOKINEN, MikaNOPPARI, Panu
    • A61K47/02A61K9/16A61K31/522
    • A61K9/0024A61K9/1611A61K31/522A61K47/02
    • This invention relates to a depot formulation comprising a biodegradable silica hydrogel composite incorporating a nucleotide or nucleoside analogue reverse transcriptase inhibitor, wherein the silica hydrogel composite is obtainable by mixing silica particles comprising said nucleotide or nucleoside analogue reverse transcriptase inhibitor and having a maximum diameter of ≤ 1 000 μm, as such or as a suspension, with silica sol wherein the hydrogel composite is non-flowing and structurally stable when stored at rest and shear-thinning when shear stress is applied by injection. The present invention also relates to use of the depot formulation for treatment of chronic viral infections and prevention of chronic viral reinfection. The present invention further relates to a prefilled syringes comprising said depot formulation.
    • 本发明涉及包含掺入核苷酸或核苷类似物逆转录酶抑制剂的生物可降解氧化硅水凝胶复合材料的贮库制剂,其中所述氧化硅水凝胶复合材料可通过将包含所述核苷酸或核苷类似物逆转录酶 抑制剂并且具有≤1000μm的最大直径,原样或作为悬浮液,其中硅溶胶中水凝胶复合材料在静态储存时结构稳定且结构稳定并且当通过注射施加剪切应力时剪切稀化。 本发明还涉及长效制剂用于治疗慢性病毒感染和预防慢性病毒再感染的用途。 本发明进一步涉及包含所述储库制剂的预填充注射器。